Blood coagulation and fibrinolysis before and after exhaustive exercise in patients with IDDM

Thrombosis and Haemostasis

Volumn 90, Issue 6, 2003, Pages 1065-1073

  Hilberg, Thomas ^a   Eichler, Evelyn ^a   Gläser, Doreen ^a   Prasa, Dagmar ^a   Stürzebecher, Jörg ^a   Gabriel, Holger H W ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

F1+2; PAI 1; TAT; Thrombin potential; tPA

Indexed keywords

ANTIGEN; CHOLESTEROL; CREATININE; D DIMER; FIBRINOGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LACTIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLASMIN ALPHA2 ANTIPLASMIN COMPLEX; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 1 ANTIGEN; PROTEIN; PROTHROMBIN; THROMBIN; THROMBIN ANTITHROMBIN COMPLEX; TISSUE PLASMINOGEN ACTIVATOR; TISSUE PLASMINOGEN ACTIVATOR ANTIGEN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING PARAMETERS; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC RETINOPATHY; EXERCISE TEST; EXHAUSTION; FIBRINOGEN BLOOD LEVEL; FIBRINOLYSIS; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; LACTATE BLOOD LEVEL; LIPID BLOOD LEVEL; MALE; METABOLIC REGULATION; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; PROTHROMBIN TIME; REST; STATISTICAL ANALYSIS;

EID: 0348163661     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/th03-05-0264     Document Type: Article

References (50)

1. Takahashi H, Tsuda A, Tatewaki W, et al. Activation of blood coagulation and fibrinolysis in diabetes mellitus: Evaluation by plasma levels of thrombin-antithrombin III complex and plasmin-alpha 2-plasmin inhibitor complex. Thromb Res 1989; 55: 727-35.
2. Carr ME. Diabetes mellitus: A hypercoagulable state. J Diabetes Complications 2001; 15: 44-54.
3. Acang N, Jalil FD. Hypercoagulation in diabetes mellitus. Southeast Asian J Trop Med Public Health 1993; 24 Suppl 1: 263-6.
4. Reverter JL, Reverter JC, Tassies D, et al. Thrombomodulin and induced tissue factor expression on monocytes as markers of diabetic microangiopathy: A prospective study on hemostasis and lipoproteins in insulin-dependent diabetes mellitus. Am J Hematol 1997; 56: 93-9.
5. Yokoyama H, Myrup B, Rossing P, et al. Increased tissue factor pathway inhibitor activity in IDDM patients with nephropathy. Diabetes Care 1996; 19: 441-5.
6. Davi G, Gennaro F, Spatola A, et al. Thrombin-antithrombin III complexes in type II diabetes mellitus. J Diabetes Complications 1992; 6: 7-11.
7. Morishita E, Asakura H, Jokaji H, et al. Hypercoagulability and high lipoprotein(a) levels in patients with type II diabetes mellitus. Atherosclerosis 1996; 120: 7-14.
8. Lopez Y, Paloma MJ, Rifon J, et al. Measurement of prethrombotic markers in the assessment of acquired hypercoagulable states. Thromb Res 1999; 93: 71-8.
9. Sumida Y, Wada H, Fujii M, et al. Increased soluble fibrin monomer and soluble thrombomodulin levels in non-insulin-dependent diabetes mellitus. Blood Coagul Fibrinolysis 1997; 8: 303-7.
10. Van Wersch JW, Westerhuis LW, Venekamp WJ. Coagulation activation in diabetes mellitus. Haemostasis 1990; 20: 263-9.
11. Hemker HC, Wielders S, Kessels H, et al. Continuous registration of thrombin generation in plasma, its use for the determination of the thrombin potential. Thromb Haemost 1993; 70: 617-24.
12. Aso Y, Fujiwara Y, Tayama K, et al. Relationship between soluble thrombomodulin in plasma and coagulation or fibrinolysis in type 2 diabetes. Clin Chim Acta 2000; 301: 135-45.
13. Wieczorek I, Pell AC, McIver B, et al. Coagulation and fibrinolytic systems in type I diabetes: Effects of venous occlusion and insulin-induced hypoglycaemia. Clin Sci (Lond) 1993; 84: 79-86.
14. Takada Y, Urano T, Watanabe I, et al. Changes in fibrinolytic parameters in male patients with type 2 (non-insulin-dependent) diabetes mellitus. Thromb Res 1993; 71: 405-15.
15. Brandenburg SL, Reusch JE, Felder KK, et al. Impaired fibrinolysis in premenopausal women and age-matched men with Type 2 diabetes mellitus: A pilot study. J Investig Med 2002; 50: 110-5.
16. Sharma SC. Platelet adhesiveness, plasma fibrinogen, and fibrinolytic activity in juvenile-onset and maturity-onset diabetes mellitus. J Clin Pathol 1981; 34: 501-3.
17. Leurs PB, Stolk RP, Hamulyak K, et al. Tissue factor pathway inhibitor and other endothelium-dependent hemostatic factors in elderly individuals with normal or impaired glucose tolerance and type 2 diabetes. Diabetes Care 2002; 25: 1340-5.
18. Cho YW, Yang DH, Oh DY, et al. Plasma t-PA and PAI-1 antigen concentrations in non-insulin dependent diabetic patients: Implication for diabetic retinopathy. Diabetes Res Clin Pract 1994; 22: 123-8.
19. Walmsley D, Hampton KK, Grant PJ. Contrasting fibrinolytic responses in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes. Diabet Med 1991; 8: 954-9.
20. Vicari AM, Vigano D'Angelo S, Testa S, et al. Normal tissue plasminogen activator and plasminogen activator inhibitor activity in plasma from patients with type 1 diabetes mellitus. Horm Metab Res 1992; 24: 516-9.
21. Weiss C, Seitel G, Bartsch P. Coagulation and fibrinolysis after moderate and very heavy exercise in healthy male subjects. Med Sci Sports Exerc 1998; 30: 246-51.
22. Bartsch P, Welsch B, Albert M, et al. Balanced activation of coagulation and fibrinolysis after a 2-h triathlon. Med Sci Sports Exerc 1995; 27: 1465-70.
23. Hilberg T, Nowacki PE, Muller-Berghaus G, et al. Changes in blood coagulation and fibrinolysis associated with maximal exercise and physical conditioning in women taking low dose oral contraceptives. J Sci Med Sport 2000; 3: 383-90.
24. Hilberg T, Prasa D, Sturzebecher J, et al. Thrombin potential and thrombin generation after exhaustive exercise. Int J Sports Med 2002; 23: 500-4.
25. Dunstan DW, Mori TA, Puddey IB, et al. A randomised, controlled study of the effects of aerobic exercise and dietary fish on coagulation and fibrinolytic factors in type 2 diabetics. Thromb Haemost 1999; 81: 367-72.
26. Ibbotson SH, Gough SC, Rice PJ, et al. The effect of short-term exercise on plasma procoagulant activity in patients with type II (non-insulin-dependent) diabetes and healthy volunteers. Thromb Res 1993; 71: 149-58.
27. Schneider SH, Kim HC, Khachadurian AK, et al. Impaired fibrinolytic response to exercise in type II diabetes: Effects of exercise and physical training. Metabolism 1988; 37: 924-9.
28. Stegman H, Kindermann W, Schnabel A. Lactate kinetics and individual anaerobic threshold. Int J Sports Med 1981; 2: 160-5.
29. Dill DB, Costill DL. Calculation of percentage changes in volumes of blood, plasma, and red cells in dehydration. J Appl Physiol 1974; 37: 247-8.
30. Prasa D, Svendsen L, Sturzebecher J. Inhibition of thrombin generation in plasma by inhibitors of factor Xa. Thromb Haemost 1997; 78: 1215-20.
31. Prasa D, Svendsen L, Sturzebecher J. The ability of thrombin inhibitors to reduce the thrombin activity generated in plasma on extrinsic and intrinsic activation. Thromb Haemost 1997; 77: 498-503.
32. Garcia Frade LJ, De La Calle H, Alava I, et al. Diabetes mellitus as a hypercoagulable state: Its relationship with fibrin fragments and vascular damage. Thromb Res 1987; 47: 533-40.
33. Williams E, Timperley WR, Ward JD, et al. Electron microscopical studies of vessels in diabetic peripheral neuropathy. J Clin Pathol 1980; 33: 462-70.
34. Hemker HC, Beguin S. Thrombin generation in plasma: Its assessment via the endogenous thrombin potential. Thromb Haemost 1995; 74: 134-8.
35. Rotteveel RC, Roozendaal KJ, Eijsman L, et al. The influence of oral contraceptives on the time-integral of thrombin generation (thrombin potential). Thromb Haemost 1993; 70: 959-62.
36. Wielders S, Mukherjee M, Michiels J, et al. The routine determination of the endogenous thrombin potential, first results in different forms of hyper- and hypocoagulability. Thromb Haemost 1997; 77: 629-36.
37. Ceriello A. Fibrinogen and diabetes mellitus: Is it time for intervention trials?. Diabetologia 1997; 40: 731-4.
38. Rigla M, Fontcuberta J, Mateo J, et al. Physical training decreases plasma thrombo-modulin in type I and type II diabetic patients. Diabetologia 2001; 44: 693-9.
39. Carmassi F, Morale M, Puccetti R, et al. Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus. Thromb Res 1992; 67: 643-54.
40. Kvasnicka J, Skrha J, Perusicova J, et al. [Levels of tissue-type plasminogen activator (T-PA), its inhibitor (PAI-1) and fibrinogen in the blood of patients with type 1 and 2 diabetes mellitus]. Cas Lek Cesk 1996; 20:174-177.
41. Avellone G, Di Garbo V, Cordova R, et al. Blood coagulation and fibrinolysis in obese NIDDM patients. Diabetes Res 1994; 25: 85-92.
42. Freeman MS, Mansfield MW, Barrett JH, et al. Insulin resistance: An atherothrombotic syndrome. Thromb Haemost 2003; 89: 161-8.
43. Potter Van Loon BJ, Kluft C, Radder JK, et al. The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistance. Metabolism 1993; 42: 945-9.
44. Landin K, Tengborn L, Smith U. Elevated fibrinogen and plasminogen activator inhibitor (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease. J Intern Med 1990; 227: 273-8.
45. Heywood DM, Mansfield MW, Grant PJ. Factor VII gene polymorphisms, factor VII:C levels and features of insulin resistance in non-insulin-dependent diabetes mellitus. Thromb Haemost 1996; 75: 401-6.
46. Asplund-Carlson A, Hamsten A, Wiman B, et al. Relationship between plasma plasminogen activator inhibitor-1 activity and VLDL triglyceride concentration, insulin levels and insulin sensitivity: Studies in randomly selected normo- and hypertriglyceridaemic men. Diabetologia 1993; 36: 817-25.
47. Morale M, De Negri F, Carmassi F. Fibrin(ogen) and diabetes mellitus: Don't forget fibrinolysis. Diabetologia 1997; 40: 735-7.
48. Sobel BE, Woodcock-Mitchell J, Schneider DJ, et al. Increased plasminogen activator inhibitor type 1 in coronary artery atherectomy specimens from type 2 diabetic compared with nondiabetic patients. A potential factor predisposing to thrombosis and its persistance. Circulation 1998; 97: 2213-21.
49. Zhang J, Ren S, Sun D, et al. Influence of glycation on LDL-induced generation of fibrinolytic regulators in vascular endothelial cells. Arterioscler Thromb Vasc Biol 1998; 18: 1140-8.
50. El-Sayed MS. Blood hemostasis in exercise and training. Med Sci Sports Exerc. 2000; 32: 918-25.